相关实验视频

Updated: Sep 16, 2025

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Macrophage Differentiation and Polarization into an M2-Like Phenotype using a Human Monocyte-Like THP-1 Leukemia Cell Line

Published on: August 2, 2021

在肺腺癌中由ANKRD22诱导的巨细胞M2两极化促进了瘤血管生成

Li Zhou¹, Dan Ma¹, Xingxing Li¹

¹Department of Medical Oncology, First People's Hospital of Linping District, Hangzhou, China.

Central-European journal of immunology

|July 7, 2025

概括

安基林重复域含有蛋白22 (ANKRD22) 通过增强M2巨细胞极化,促进肺腺癌 (LUAD) 的进展. 这导致血管新生增加,突出显示ANKRD22是LUAD的潜在治疗标.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

肺腺癌 (LUAD) 的发病率和死亡率很高.
安基林重复域含蛋白22 (ANKRD22) 在LUAD进展中的作用尚未完全理解.
ANKRD22与各种癌症的发展有关.

研究的目的:

为了阐明ANKRD22在LUAD中的生物学作用.
调查ANKRD22影响LUAD恶性瘤的机制.
探索ANKRD22之间的关系,巨细胞极化,和血管生成在LUAD.

主要方法:

使用TCGA-LUAD数据库和qRT-PCR评估了LUAD组织和细胞中的ANKRD22表达.
通过qRT-PCR,流细胞计和西部斑点检查了巨细胞极化 (THP-1衍生物).
评估ANKRD22对A549细胞增殖/迁移和HUVEC血管生成的评估效应,使用细胞试验和Transwell/管形成试验.

主要成果:

在LUAD组织和细胞中,ANKRD22表达升高.
过度表达ANKRD22促进了巨细胞中的M2极化.
抑制ANKRD22介导的M2极化减少了HUVEC迁移和管形成.

结论:

ANKRD22调解了 LUAD 恶性进展.
ANKRD22诱导了与瘤相关的巨细胞的M2极化.
这种M2极化促进了LUAD中的血管生成.

关键词:

ANKRD2222 在这里.在M2中,极化为M2.血管新生是因为血管新生.肺部腺癌瘤是什么?

更多相关视频

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages

Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages

Published on: June 23, 2013

Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis

Assessing Tumor Microenvironment of Metastasis Doorway-Mediated Vascular Permeability Associated with Cancer Cell Dissemination using Intravital Imaging and Fixed Tissue Analysis

Published on: June 26, 2019

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...